[ad_1] Profits are growing again, and the Federal Reserve looks as if it will start cutting rates sometime this year. It is an unusual combination and, for the stock market,…
Tag: MRK
Merck to Buy Harpoon Therapeutics for $680 Million
[ad_1] Merck & Co.has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680 million. Merck on Monday said it will pay $23 a share in cash…
The Stocks That AI Mania Left Behind
[ad_1] This was supposed to be the year value stocks shined. Then AI mania took over and ran away with the spotlight. Shares of big tech companies are surging this…
Earnings Estimates Are Falling. These Two Companies Are Shouldering the Blame.
[ad_1] Wall Street has slashed its estimates for corporate profits in the final months of 2023. Yet investors appear to be taking the shifting picture in stride, partly because much…
Big Pharma’s Battle With the Biden Administration Could Have Legs
[ad_1] Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the Inflation Reduction Act. [ad_2] Source link
U.S. Chamber of Commerce Challenges Federal Government’s New Drug-Price Powers
[ad_1] The lawsuit is the second filed this week saying Medicare’s new negotiating authority is unconstitutional. [ad_2] Source link
Merck Challenges U.S. Government’s New Powers to Negotiate Drug Prices
[ad_1] The drugmaker filed a lawsuit saying Medicare’s drug-price negotiation program violates the company’s constitutional rights. [ad_2] Source link